Dr Helen McShane at the University of Oxford and the Oxford-Emergent Tuberculosis Consortium Ltd have received a Strategic Award to part-fund the first trial to test efficacy of the new TB vaccine candidate, MVA85A, for potential efficacy in South African infants.
In this film Dr McShane discusses the new vaccine candidate and these trials. To find out more, visit www.wellcome.ac.uk